No Cover Image

Journal article 780 views

The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment

Ceri Phillips

CNS Drugs, Volume: 18, Issue: 9, Pages: 561 - 574

Swansea University Author: Ceri Phillips

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.2165/00023210-200418090-00002

Published in: CNS Drugs
ISSN: 1172-7047
Published: 2004
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa1249
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2013-07-23T11:46:42Z
last_indexed 2018-02-09T04:28:16Z
id cronfa1249
recordtype SURis
fullrecord <?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>1249</id><entry>2011-10-01</entry><title>The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment</title><swanseaauthors><author><sid>932c7a406ab4b6e4a881d422ca03c289</sid><firstname>Ceri</firstname><surname>Phillips</surname><name>Ceri Phillips</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2011-10-01</date><deptcode>FGMHL</deptcode><abstract/><type>Journal Article</type><journal>CNS Drugs</journal><volume>18</volume><journalNumber>9</journalNumber><paginationStart>561</paginationStart><paginationEnd>574</paginationEnd><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1172-7047</issnPrint><issnElectronic/><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2004</publishedYear><publishedDate>2004-12-31</publishedDate><doi>10.2165/00023210-200418090-00002</doi><url/><notes>The journal commissioned this research which sought to draw the issues relating to cost-effectiveness of therapies in multiple sclerosis together following considerable discussion and debate in academic/policy arenas. Comprised of a systematic review of the worlds' literature and an assessment of published economic models from across the world.</notes><college>COLLEGE NANME</college><department>Medicine, Health and Life Science - Faculty</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>FGMHL</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2023-06-28T16:22:04.7519703</lastEdited><Created>2011-10-01T00:00:00.0000000</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Ceri</firstname><surname>Phillips</surname><order>1</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling v2 1249 2011-10-01 The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment 932c7a406ab4b6e4a881d422ca03c289 Ceri Phillips Ceri Phillips true false 2011-10-01 FGMHL Journal Article CNS Drugs 18 9 561 574 1172-7047 31 12 2004 2004-12-31 10.2165/00023210-200418090-00002 The journal commissioned this research which sought to draw the issues relating to cost-effectiveness of therapies in multiple sclerosis together following considerable discussion and debate in academic/policy arenas. Comprised of a systematic review of the worlds' literature and an assessment of published economic models from across the world. COLLEGE NANME Medicine, Health and Life Science - Faculty COLLEGE CODE FGMHL Swansea University 2023-06-28T16:22:04.7519703 2011-10-01T00:00:00.0000000 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Ceri Phillips 1
title The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
spellingShingle The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
Ceri Phillips
title_short The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
title_full The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
title_fullStr The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
title_full_unstemmed The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
title_sort The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment
author_id_str_mv 932c7a406ab4b6e4a881d422ca03c289
author_id_fullname_str_mv 932c7a406ab4b6e4a881d422ca03c289_***_Ceri Phillips
author Ceri Phillips
author2 Ceri Phillips
format Journal article
container_title CNS Drugs
container_volume 18
container_issue 9
container_start_page 561
publishDate 2004
institution Swansea University
issn 1172-7047
doi_str_mv 10.2165/00023210-200418090-00002
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 0
active_str 0
published_date 2004-12-31T16:22:00Z
_version_ 1769960343495245824
score 11.012813

Similar Items